Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

INSULIN-LIKE GROWTH FACTOR II BINDING PROTEIN - ANVISA Registration 80615950044

Access comprehensive regulatory information for INSULIN-LIKE GROWTH FACTOR II BINDING PROTEIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80615950044 and manufactured by IMMUNODIAGNOSTICS SYSTEM LTD. The registration is held by Diagmaster Científica ltda with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 3 companies making the same product including SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LIMITED, IMMUNODIAGNOSTICS SYSTEM LTD, and 3 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
3 Competitors
3 Recent Registrations
80615950044
Registration Details
ANVISA Registration Number: 80615950044
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

IDS-iSYS INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3 (IGFBP-3)
Risk Class II

Registration Details

80615950044

25351418657201413

09322796000173

Company Information

United Kingdom
PT: REINO UNIDO

Dates and Status

Nov 03, 2014

VIGENTE

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "INSULIN-LIKE GROWTH FACTOR II BINDING PROTEIN"